| Bid Price | 0.35p | High Price | 0.38p |
|---|
| Ask Price | 0.38p | Low Price | 0.33p |
|---|
| Open Price | 0.34p | Spread | 7.89% |
|---|
| Prev Close | 0.34p | Volume | 13,757,355 |
|---|
Valirx PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 11, 2025 | 0.34 | 0.38 | 0.33 | 0.36 | 13,757,355 |
| Dec 10, 2025 | 0.35 | 0.35 | 0.32 | 0.34 | 26,112,040 |
| Dec 9, 2025 | 0.39 | 0.39 | 0.33 | 0.35 | 33,945,440 |
| Dec 8, 2025 | 0.33 | 0.42 | 0.32 | 0.39 | 38,458,267 |
| Dec 5, 2025 | 0.39 | 0.40 | 0.33 | 0.33 | 17,318,342 |
Valirx PLC Information
| Name | Valirx PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BLH13C52 | Epic | VAL |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASX1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 500,000 | Trading Status | Closed |
|---|
| Shares in Issue | 742.72 m | Prev Close | 0.34p |
|---|
| PE Ratio | | Market Cap | £2.71 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.216007 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 9.658204 | Quick Ratio | 6.674591 |
|---|
Valirx PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 20/11/25 | PLAC | Gerald Desler | ED | 1,200,000 @ £0.00 | £3,000.00 |
| 20/11/25 | PLAC | Mark Eccleston | CEO | 36,000,000 @ £0.00 | £90,000.00 |
| 20/11/25 | PLAC | Martin Gouldstone | NED | 1,200,000 @ £0.00 | £3,000.00 |
| 20/11/25 | PLAC | Catherine Tralau-Stewart | ED | 1,200,000 @ £0.00 | £3,000.00 |
| 31/12/24 | TIN | Mark Eccleston | CEO | 3,076,923 @ £0.00 | £0.00 |
| 30/12/24 | TIN | Gerald Desler | ED | 769,231 @ £0.00 | £0.00 |
| 30/12/24 | TIN | Adrian de Courcey | RES | 1,538,461 @ £0.00 | £0.00 |
| 30/12/24 | TIN | Catherine Tralau-Stewart | ED | 769,231 @ £0.00 | £0.00 |
| 04/01/24 | PLAC | Gerald Desler | ED | 66,666 @ £0.06 | £4,000.00 |
| 04/01/24 | PLAC | Stella Panu | RES | 333,333 @ £0.06 | £20,000.00 |
Valirx PLC News
